Rilematovir
- Generic Name
- Rilematovir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H20ClF3N4O3S
- CAS Number
- 1383450-81-4
- Unique Ingredient Identifier
- NQ99E8OH3P
- Background
Rilematovir is under investigation in clinical trial NCT04056611 (Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)).
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath